The interleukin-17 receptor plays a gender-dependent role in host protection against Porphyromonas gingivalis-induced periodontal bone loss

Infection and Immunity

Volumn 76, Issue 9, 2008, Pages 4206-4213

  Yu, Jeffrey J ^a   Ruddy, Matthew J ^a   Conti, Heather R ^b   Boonanantanasarn, Kanitsak ^b   Gaffen, Sarah L ^a,b,c  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; CHEMOKINE; CHEMOKINE GRO ALPHA; CHEMOKINE KC; CHEMOKINE MIP 2; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DESTRUCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; FEMALE; GENDER; IMMUNE RESPONSE; MALE; MOUSE; MOUSE STRAIN; NEUTROPHIL; NONHUMAN; OSTEOLYSIS; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN FUNCTION; SEX DIFFERENCE; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL; UPREGULATION;

ALVEOLAR BONE LOSS; ANIMALS; ANTIBODIES, BACTERIAL; BACTEROIDACEAE INFECTIONS; CHEMOKINE CXCL1; CHEMOKINE CXCL2; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOGLOBULIN G; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PORPHYROMONAS GINGIVALIS; RECEPTORS, INTERLEUKIN-17; SEX FACTORS;

EID: 51949097521     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01209-07     Document Type: Article

References (67)

1. Aarvak, T., M. Chabaud, P. Miossec, and J. B. Natvig. 1999. IL-17 is produced by some proinflammatory Thl/ThO cells but not by Th2 cells. J. Immunol. 162:1246-1251.
2. Aggarwal, S., N. Ghilardi, M. H. Xie, F. J. De Sauvage, and A. L. Gurney. 2002. Interleukin 23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin 17. J. Biol. Chem. 3:1910-1914.
3. Aggarwal, S., and A. L. Gurney. 2002. IL-17: a prototype member of an emerging family. J. Leukoc. Biol. 71:1-8.
4. Baker, P. J. 2005. Genetic control of the immune response in pathogenesis. J. Periodontol. 76:2042-2046.
5. + T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice. Infect. Immun. 67:2804-2809.
6. Baker, P. J., M. Dixon, and D. C. Roopenian. 2000. Genetic control of susceptibility to Porphyromonas gingivalis-induced alveolar bone loss in mice. Infect. Immun. 68:5864-5868.
7. Baker, P. J., L. DuFour, M. Dixon, and D. C. Roopenian. 2000. Adhesion molecule deficiencies increase Porphyromonas gingivalis-induced alveolar bone loss in mice. Infect. Immun. 68:3103-3107.
8. Baker, P. J., R. T. Evans, and D. C. Roopenian. 1994. Oral infection with Porphyromonas gingivalis and induced alveolar bone loss in immunocompetent and severe combined immunodeficient mice. Arch. Oral Biol. 39:1035-1040.
9. Beertsen, W., M. Willenborg, V. Everts, A. Zirogianni, R. Podschun, B. Schroder, E. L. Eskelinen, and P. Saftig. 2008. Impaired phagosomal maturation in neutrophils leads to periodontitis in lysosomal-associated membrane protein-2 knockout mice. J. Immunol. 180:475-482.
10. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector T(H)17 and regulatory T cells. Nature 441:235-238.
11. Burt, B. 2005. Position paper: epidemiology of periodontal diseases. J. Periodontol. 76:1406-1419.
12. Dong, C. 2006. Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells. Nat. Rev. 6:329-333.
13. Dunn, S. E., S. S. Ousman, R. A. Sobel, L. Zuniga, S. E. Baranzini, S. Youssef, A. Crowell, J. Loh, J. Oksenberg, and L. Steinman. 2007. Peroxisome proliferator-activated receptor (PPAR) alpha expression in T cells mediates gender differences in development of T cell-mediated autoimmunity. J. Exp. Med. 204:321-330.
14. Reference deleted.
15. Fossiez, F., O. Djossou, P. Chomarat, L. Flores-Romo, S. Ait-Yahia, C. Maat, J. J. Pin, P. Garrone, E. Garcia, S. Saeland, D. Blanchard, C. Gaillard, B. Das Mahapatra, E. Rouvier, P. Golstein, J. Banchereau, and S. Lebecque. 1996. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183:2593-2603.
16. Galen, S. L. 2004. Interleukin-17: a unique inflammatory cytokine with roles in bone biology and arthritis. Arth. Res. Ther. 6:240-247.
17. Gaffen, S. L., and G. Hajishengallis. A. new inflammatory cytokine on theblock: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. J. Dental Res., in press.
18. Gaffen, S. L., J. M. Kramer, J. J. Yu, and F. Shen. 2006. The IL-17 cytokine family. Vitamins Hormones 74:255-282.
19. Genco, R. J., S. G. Grossi, A. Ho, F. Nishimura, and Y. Murayama. 2005. A. proposed model linking inflammation to obesity, diabetes, and periodontal infections. J. Periodontol. 76:2075-2084.
20. Ghilardi, N., and W. Ouyang. 2007. Targeting the development and effector functions of Th17 cells. Semin. Immunol. 19:383-393.
21. Graves, D. T., Y.-T. A. Teng, T. Van Dyke, and G. Hajishengallis. The use of rodent models of investigate host-bacteria interactions related to periodontal diseases. J. Clin. Periodontol., in press.
22. Gregory, M. S., D. E. Faunce, L. A. Duffner, and E. J. Kovacs. 2000. Gender difference in cell-mediated immunity after thermal injury is mediated, in part, by elevated levels of interleukin-6. J. Leukoc. Biol. 67:319-326.
23. Heitz-Mayfield, L. J. 2005. Disease progression: identification of high-risk groups and individuals for periodontitis. J. Clin. Periodontol. 32(Suppl. 6): 196-209.
24. Huang, W., L. Na, P. L. Fidel, and P. Schwarzenberger. 2004. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis. 190:624-631.
25. Infante-Duarte, C., H. F. Horton, M. C. Byrne, and T. Kamradt. 2000. Microbial Iipopeptides induce the production of IL-17 in Th cells. J. Immunol. 165:6107-6115.
26. Johnson, R. B., N. Wood, and F. G. Serio. 2004. Interleukin-11 and IL-17 and the pathogenesis of periodontal disease. J. Periodontol. 75:37-43.
27. Kantarci, A., and T. E. Van Dyke. 2002. Neutrophil-mediated host response to Porphyromonas gingivalis. J. Int. Acad. Periodontol. 4:119-125.
28. Kelly, M. N., J. K. Kolls, K. Happel, J. D. Schwartzman, P. Schwarzenberger, C. Combe, M. Moretto, and I. A. Khan. 2005. Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infect. Immun. 73:617-621.
29. Kikly, K., L. Liu, S. Na, and J. D. Sedgwick. 2006. The IL-23mi(17) axis: therapeutic targets for autoimmune inflammation. Curr. Opin. Immunol. 18:670-675.
30. Klausen, B., C. Sfintescu, and R. T. Evans. 1991. Asymmetry in periodontal bone loss of gnotobiotic Sprague-Dawley rats. Arch. Oral Biol. 36:685-687.
31. Korn, T., E. Bettelli, W. Gao, A. Awasthi, A. Jager, T. B. Strom, M. Oukka, and V. K. Kuchroo. 2007. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448:484-487.
32. Kotake, S., N. Udagawa, N. Takahashi, K. Matsuzaki, K. Itob, S. Ishiyama, S. Saito, K. Inoue, N. Kamatani, M. T. Gillespie, T. J. Martin, and T. Suda. 1999. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Investig. 103:1345-1352.
33. Kramer, J., and S. Gaffen. 2007. Interleukin-17: a new paradigm in inflammation, autoimmunity and therapy. J. Periodontol. 78:1083-1093.
34. Laurence, A., and J. O'Shea. 2007. Th-17 differentiation: of mice and men. Nat. Immunol. 8:903-905.
35. Lester, S. R., J. L. Bain, R. B. Johnson, and F. G. Serio. 2007. Gingival concentrations of interleukin-23 and -17 at healthy sites and at sites of clinical attachment loss. J. Periodontol. 78:1545-1550.
36. Lindén, A., M. Laan, and G. Anderson. 2005. Neutrophils, interleukin-17A and lung disease. Eur. Respir. J. 25:159-172.
37. Mangan, P. R., L. E. Harrington, B. O'Quinn, D. W. S. Helms, D. C. Bullard. C. O. Elson, R. D. Hatton, S. M. Wahl, T. R. Schoeb, and C. T. Weaver. 2006. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441:231-234.
38. McGeachy, M. J., K. S. Bak-Jensen, Y. Chen, C. M. Tato, W. Blumenschein, T. McClanahan. and D. J. Cua. 2007. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat. Immunol. 8:1390-1397.
39. Mclnnes, I. B., and G. Schett. 2007. Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. 7:429-442.
40. Miossec, P. 2003. Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy. Arthritis Rheum. 48:594-601.
41. Moseley, T. A., D. R. Haudenschild, L. Rose, and A. H. Reddi. 2003. interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 14:155-174.
42. Niedennan, R., T. Westernoff, C. Lee, L. L. Mark, N. Kawashima, M. Ullman-Culler, F. E. Dewhirst, B. J. Paster, D. D. Wagner, T. Mayadas, R. O. Hynes, and P. Stashenko. 2001. Infection-mediated early-onset periodontal disease in P/E-selectin-deficient mice. J. Clin. Periodontol. 28:569-575.
43. Nurieva, R., X. O. Yang, G. Martinez, Y. Zhang, A. D. Panopoulos, L. Ma, K. Schluns, Q. Tian, S. S. Watowich, A. M. Jetten, and C. Dong. 2007. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448:480-483.
44. O'Dell, J. R. 2004. Therapeutic strategies for rheumatoid arthritis. N. Engl. J. Med. 350:2591-2602.
45. O'Shea, J. J., A. Ma, and P. Lipsky. 2002. Cytokines and autoimmunity. Nat. Rev. 2:37-45.
46. Reddy, J., H. Waldner, X. Zhang, Z. Illes, K. W. Wucherpfennig, R. A. Sobel, and V. K. Kuchroo. 2005. Cutting edge: CD4+ CD25+ regulatory T cells contribute to gender differences in susceptibility to experimental autoimmune encephalomyelitis. J. Immunol. 175:5591-5595.
47. Rouvier, E., M. F. Luciani, M. G. Mattei, F. Denizot, and P. Golstein. 1993. CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J. Immunol. 150:5445-5456.
48. Ruddy, M. J., F. Shen, J. B. Smith, A. Sharma, and S. L. Gaffen. 2004. Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment. J. Leukoc. Biol. 76:135-144.
49. Ruddy, M. J., G. C. Wong, X. K. Liu, H. Yamamoto, S. Kasayama, K. L. Kirkwood, and S. L. Gaffen. 2004. Functional cooperation between interleukin-17 and tumor necrosis factor-α is mediated by CCAAT/enhancer binding protein family members. J. Biol. Chem. 279:2559-2567.
50. Scannapieco, F. A., and R. J. Genco. 1999. Association of periodontal infections with atherosclerotic and pulmonary diseases. J. Periodontal Res. 34: 340-345.
51. Schwarzenberger, P., V. La Russa, A. Miller, P. Ye, W. Huang, A. Zieske, S. Nelson, G. J. Bagby, D. Stoltz, R. L. Mynatt, M. Spriggs, and J. K. Kolls. 1998. IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J. Immunol. 161:6383-6389.
52. Shen, F., and S, L. Gaffen. 2008. Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy. Cytokine 41:92-104.
53. Shen, F., M. J. Ruddy, P. Plamondon, and S. L. Gaffen. 2005. Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-alpha-induced genes in bone cells. J. Leukoc. Biol. 77:388-399.
54. Shin, H. C., N. Benbernou, S. Esnault, and M. Guenounou. 1999. Expression of IL-17 in human memory CD45RO+ T lymphocytes and its regulation by protein kinase A. pathway. Cytokine 11:257-266.
55. Stark, M. A., Y. Huo, T. L. Burcin, M. A. Morris, T. S. Olson, and K. Ley. 2005. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 22:285-294.
56. Steinman, L. 2007. A. brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat. Med. 13: 139-145.
57. Takahashi, K., T. Azuma, H. Motohira, D. F. Kinane, and S. Kitetsu. 2005. The potential role of interleukin-17 in the immunopathology of periodontal disease. J. Clin. Periodontol. 32:369-374.
58. Teng, Y. T. 2003. The role of acquired immunity and periodontal disease progression. Crit. Rev. Oral Biol. Med. 14:237-252.
59. Veldhoen, M., R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger. 2006. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179-189.
60. Walker, W., C. W. Roberts, D. J. Ferguson, H. Jebbari, and J. Alexander. 1997. Innate immunity to Toxoplasma gondii is influenced by gender and is associated with differences in interleukin-12 and gamma interferon production. Infect. Immun. 65:1119-1121.
61. Weaver, C. T., R. D. Hatton, P. R. Mangan, and L. E. Harrington. 2007. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25:821-852.
62. Whitacre, C. C., S. C. Reingold, and P. A. O'Looney. 1999. A gender gap in autoimmunity. Science 283:1277-1278.
63. Witowski, J., K. Pawlaczyk, A. Breborowicz, A. Scheuren, M. Kuzlan-Pawlaczyk, J. Wisniewska, A. Polubinska, H. Friess, G. M. Gahl, L. Frei, and A. Jorres. 2000. IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J. Immunol. 165:5814-5821.
64. Yao, Z., W. C. Fanslow, M. F. Seldin, A. M. Rousseau, S. L. Painter, M. R. Comeau, J. I. Cohen, and M. K. Spriggs. 1995. Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 3:811-821.
65. Ye, P., F. H. Rodriguez, S. Kanaly, K. L. Stocking, J. Schurr, P. Schwarzenberger, P. Oliver, W. Huang, P. Zhang, J. Zhang, J. E. Shellito, G. J. Bagby, S. Nelson, K. Charrier, J. J. Peschon, and J. K. Kolls. 2001. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194:519-527.
66. Yu, J. J., M. J. Ruddy, G. C. Wong, C. Sfintescu, P. J. Baker, J. B. Smith, R. T. Evans, and S. L. Gaffen. 2007. An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood 109:3794-3802.
67. Zhou, L., I. I. Ivanov, R. Spolski, R. Min, K. Shenderov, T. Egawa, D. E. Levy, W. J. Leonard, and D. R. Littman. 2007. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 9:967-974.